NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)

The summary for the NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required): The NEI uses this U44 Notice of Funding Opportunity to support SBIR grant applications from small business concerns (SBCs) that propose to implement investigator-initiated, early-stage clinical trials with greater than minimal risk and typically are Phase I or II trials. The risk level of the U44 trial requires appropriate performance oversight and safety monitoring. For purposes of this NOFO, the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders. Applicants are strongly advised to consult with NEI program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity.

Federal Grant Title:	NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-24-066
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.867
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 7th, 2027
Original Application Deadline:	January 7th, 2027
Posted Date:	December 1st, 2023
Creation Date:	December 1st, 2023
Archive Date:	February 12th, 2027
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	December 1st, 2023

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-24-066.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program (R...; • NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Opti...; • NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed); • NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed); • NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional); • Nei Career Transition Award (K22); • NEI Translational Research Program On Therapy For Visual Disorders; • NEI Clinical Study Planning Grant Program (R34)
More Grants from the National Institutes of Health: • Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translati...; • Integrative Research to Understand the Impact of Sex Differences on the Molecular Determin...; • Limited Competition: Mentored Research Career Development Program Award in Clinical and Tr...; • Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Option...; • Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clini...